Nyumbani › Kasinoma ya Selu Basal
Majaribio ya kliniki ya Kasinoma ya Selu Basal yanayovutia washiriki nchini Marekani
Masomo 20 ya Kasinoma ya Selu Basal yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- Rochester, NYUtafiti 4
- Houston, TXUtafiti 4
- New York City, NYUtafiti 4
- San Diego, CAUtafiti 3
- Atlanta, GAUtafiti 3
- Columbus, OHUtafiti 3
Kwa jimbo
- CaliforniaUtafiti 4
- FloridaUtafiti 7
- GeorgiaUtafiti 3
- MarylandUtafiti 4
- New YorkUtafiti 10
- OhioUtafiti 4
- TexasUtafiti 4
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07285044Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT07182240Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 31 Ago 2026 · NCT05896839Two-photon Fluorescence Microscopy of Dermatologic Biopsies
Inaajiri
Umri wote · Jinsia zote · Imesasishwa 19 Ago 2026 · NCT07773688Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies
Inaajiri
Umri wote · Jinsia zote · Imesasishwa 19 Ago 2026 · NCT07682831Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Ago 2026 · NCT07241585A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 12 Ago 2026 · NCT05859074A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 11 Ago 2026 · NCT05592626Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
InaajiriHatua ya kwanza ya awali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 31 Jul 2026 · NCT07628634L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 31 Jul 2026 · NCT07227350Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Jul 2026 · NCT06624475L19IL2/TNF in Patients With Basal Cell Carcinoma
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 21 Jul 2026 · NCT07227870A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
InaajiriHatua ya kwanza ya awali
Umri 18 na zaidi · Jinsia zote · Imesasishwa 5 Jun 2026 · NCT07286318Raman Spectroscopy and Skin Cancer
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 7 Mei 2026 · NCT06384924Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 29 Apr 2026 · NCT03521830Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 29 Jan 2026 · NCT06623201Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 17 Sep 2025 · NCT07010692A Beta-only IL-2 ImmunoTherapY Study
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Jul 2025 · NCT05086692Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy
Inaajiri
Umri wote · Jinsia zote · Imesasishwa 17 Mac 2025 · NCT06473103To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 20 Sep 2024 · NCT06344052Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.